We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+21.34%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.42B
AUM Growth
+$56M
Cap. Flow
-$150M
Cap. Flow %
-10.6%
Top 10 Hldgs %
21.01%
Holding
400
New
86
Increased
74
Reduced
172
Closed
62

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$32.9M
2
DEN
Denbury Inc.
DEN
+$29.4M
3
ABG icon
Asbury Automotive
ABG
+$15.8M
4
FOXA icon
Fox Class A
FOXA
+$12.3M
5
STLA icon
Stellantis
STLA
+$11.7M

Sector Composition

Rank Sector Weight
1 Financials 18.93%
2 Energy 16.81%
3 Consumer Discretionary 16.27%
4 Industrials 13.92%
5 Healthcare 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
201
DELISTED
Exact Sciences
EXAS
$1.07M 0.08%
8,097
+1,165
+17% +$159K
PRTY
202
DELISTED
Party City Holdco Inc.
PRTY
$1.04M 0.07%
178,941
+78,766
+79% +$573K
NSTG
203
DELISTED
NanoString Technologies, Inc.
NSTG
$1.03M 0.07%
15,669
+5,978
+62% +$420K
HBI
204
DELISTED
Hanesbrands
HBI
$1.02M 0.07%
+51,695
New +$915K
FSKR
205
DELISTED
FS KKR Capital Corp. II
FSKR
$1.01M 0.07%
51,643
-7,170
-12% -$130K
ITHXU
206
DELISTED
ITHAX Acquisition Corp. Unit
ITHXU
$1M 0.07%
+100,055
New +$1.02M
WOLF icon
207
Wolfspeed
WOLF
$1.2B
$998K 0.07%
9,226
+1,391
+18% +$156K
FSK icon
208
FS KKR Capital
FSK
$2.98B
$986K 0.07%
49,707
-3,872
-7% -$72.1K
XLRN
209
DELISTED
Acceleron Pharma
XLRN
$980K 0.07%
7,230
-248
-3% -$32K
UPST icon
210
Upstart Holdings
UPST
$2.58B
$978K 0.07%
+7,589
New +$582K
VGSH icon
211
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$956K 0.07%
15,535
-35,861
-70% -$2.21M
SI
212
DELISTED
Silvergate Capital Corporation
SI
$948K 0.07%
+6,669
New +$791K
T icon
213
AT&T
T
$165B
$934K 0.07%
40,845
-44,447
-52% -$983K
ORGO icon
214
Organogenesis Holdings
ORGO
$308M
$923K 0.07%
+50,652
New +$686K
HASI icon
215
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
$922K 0.06%
16,435
+4,708
+40% +$283K
NTAP icon
216
NetApp
NTAP
$32.9B
$908K 0.06%
12,496
+1,567
+14% +$105K
HYACU
217
DELISTED
Haymaker Acquisition Corp. III Unit
HYACU
$908K 0.06%
+91,365
New +$912K
IGIB icon
218
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
$904K 0.06%
15,270
-6,870
-31% -$416K
URI icon
219
United Rentals
URI
$71.1B
$897K 0.06%
2,725
-478
-15% -$135K
DIS icon
220
Walt Disney
DIS
$165B
$863K 0.06%
4,677
+324
+7% +$59.8K
TDOC icon
221
Teladoc Health
TDOC
$1.58B
$861K 0.06%
4,738
+1,195
+34% +$277K
HERAU
222
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
$859K 0.06%
+85,995
New +$864K
ULTA icon
223
Ulta Beauty
ULTA
$20.4B
$832K 0.06%
2,690
VOYA icon
224
Voya Financial
VOYA
$8.94B
$827K 0.06%
12,999
SLRC icon
225
SLR Investment Corp
SLRC
$706M
$824K 0.06%
46,387
-15,275
-25% -$280K

Similar funds

Advisory Research's Q1 2021 Portfolio in Review

As of Q1 2021, Advisory Research held 400 positions worth $1.42B, up 4.1% from $1.36B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Advisory Research withdrew a net $150M in Q1 2021, closing 62 positions and reducing 172 holdings. Its most notable exit was British American Tobacco, an estimated $35.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Energy and Consumer Discretionary.

Against the trend, Advisory Research opened a new position in Devon Energy worth $34.9M.

  • Advisory Research's largest Q1 2021 buy was Devon Energy: 1,596,742 shares worth $34.9M.
  • Advisory Research added most to Cannae Holdings in Q1 2021, an estimated $8.24M increase.
  • Advisory Research's biggest Q1 2021 reduction was TSMC, cutting an estimated $35.1M.
  • Advisory Research fully exited British American Tobacco in Q1 2021, selling an estimated $35.1M.
  • Advisory Research's ten largest holdings make up 21% of its $1.42B portfolio in Q1 2021.
  • Advisory Research opened 86 new positions and closed 62 in Q1 2021.
  • Advisory Research's portfolio value rose 4.1% quarter-over-quarter to $1.42B.

Based on Advisory Research's 13F filing for Q1 2021, filed 12 May 2021.